Net profit of Ishita Drugs & Industries declined 9.52% to Rs 0.19 crore in the quarter ended September 2024 as against Rs 0.21 crore during the previous quarter ended September 2023. Sales declined 25.68% to Rs 3.27 crore in the quarter ended September 2024 as against Rs 4.40 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales3.274.40 -26 OPM %7.035.00 - PBDT0.280.31 -10 PBT0.250.28 -11 NP0.190.21 -10 Powered by Capital Market - Live News

Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live News

Ishita Drugs & Industries announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News

Net profit of Ishita Drugs & Industries rose 7.14% to Rs 0.15 crore in the quarter ended June 2024 as against Rs 0.14 crore during the previous quarter ended June 2023. Sales declined 1.94% to Rs 3.03 crore in the quarter ended June 2024 as against Rs 3.09 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales3.033.09 -2 OPM %5.945.83 - PBDT0.230.22 5 PBT0.200.19 5 NP0.150.14 7 Powered by Capital Market - Live News

Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live News